ARIA (Allergic Rhinitis and Its Impact on Asthma) Classification of Allergic Rhinitis Severity in Clinical Practice in France

Abstract

Background: The Allergic Rhinitis and Its Impact on Asthma (ARIA) workshop proposes a classification of allergic rhinitis severity. It does not take into account impairment in quality of life and treatment should be adapted accordingly. Methods: Two cross-sectional surveys were designed:a spring survey, for which 1,321 practitioners enrolled 3,026 patients consulting for seasonal allergic rhinitis and an autumn-winter survey, for which 1,346 practitioners enrolled 3,507 patients consulting for perennial allergic rhinitis. Simple quality of life parameters were included and logistic regressions were performed in order to assess the impairment of quality of life. Results: The majority of the patients were experiencing an impairment on their quality of life (92.2%). Except for cough, these patients had significantly more nasal, lung and ocular symptoms. In a multivariate analysis, rhinorrhea, nasal itching, red eyes, dyspnea, change in voice, fatigue and headache were correlated to impairment of quality of life. Persistent rhinitis was associated only with subjects who expressed difficulties in reading, and intermittent rhinitis with those who had to blow their nose and who expressed an impact on their professional activities. Conclusions: The proposal of the ARIA expert panel defining the severity of allergic rhinitis based on quality of life parameters is likely to simplify daily physician practice.

Profile of Patients with Allergic Rhinitis: A Clinic Based Cross-Sectional Study from Kolkata, India

“…Alyasin and Amin in their clinic based study in Iran found that the most common category was "moderate/severe persistent" (58.3%) followed by "mild persistent" (34.4%) and "moderate severe intermittent" (4.2%) while "mild intermittent" category was the rarest (2.1%) [18]. Other studies also reported "moderate/severe persistent" as the most common form at the time of presentation [19,20]. It was observed in the present study, that "blockers" had significantly more sensitization than "sneezers-runners" to polyvalent house dust, house dust mites and fungi, while, "sneezers-runner" had more sensitization to pollens than "blockers".…”

MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

“…Measures of AR control include (i) symptom scores, (ii) patient self-administered visual analogue scales (VAS) (16,(76)(77)(78)(79)(80)(81), (iii) objective measures of nasal obstruction (such as peak nasal inspiratory flow, acoustic rhinometry and rhinomanometry) (82), (iv) a recent modification of the ARIA severity classification (83), (v) patients' reported outcomes such as quality of life (QOL) (7, 63) scores with several items (80,84) or composite symptom-medication scores (85). However, it is important to make the score for clinical use simple and responsive to change.…”

Perennial rhinitis

“…Table 2 shows the comparative effectiveness of drugs for allergic rhinitis. [4][5][6][7][8][9][10][11][12][13][14][15] A recent review of randomised controlled trials confirmed the efficacy of antihistamines in persistent allergic rhinitis. 16 Most patients will attain good control on intranasal steroids, and a large body of data shows that they are effective for all symptoms of allergic perennial rhinitis, including nasal obstruction, itching, sneezing, and watery rhinorrhoea.…”